Insights

Innovative Therapeutics Development Alpha-1 Biologics' focus on developing patented immune cell therapies positions it as a key player in advanced biotherapeutics, offering opportunities for partnerships or supply agreements with companies looking to enhance cancer and immunodeficiency treatment pipelines.

Growth Potential With reported revenues between 1 million and 10 million and a small team of 2-10 employees, Alpha-1 Biologics is in a growth or early expansion phase, making it a promising candidate for investment, strategic collaborations, or product development support.

Research Focus The company's dedication to cutting-edge research supported by prestigious organizations suggests a high potential for breakthrough innovations, creating opportunities for technology licensing, joint research initiatives, or advanced instrumentation supplies.

Market Alignment Positioned within the biotechnology research industry, Alpha-1 Biologics serves a niche related to immune deficiencies and cancer, enabling sales opportunities with biotech firms, healthcare providers, and research institutions seeking novel immunotherapy solutions.

Digital Presence Alpha-1 Biologics maintains an active digital platform through Squarespace, supporting visibility and engagement, which offers avenues for digital marketing tools, website enhancement services, or data analytics solutions to improve outreach and stakeholder communication.

Alpha-1 Biologics Tech Stack

Alpha-1 Biologics uses 8 technology products and services including Squarespace, Open Graph, Webpack, and more. Explore Alpha-1 Biologics's tech stack below.

  • Squarespace
    Content Management System
  • Open Graph
    Content Management System
  • Webpack
    Development
  • Squarespace Commerce
    E-commerce
  • Google Fonts API
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • Stimulus
    Javascript Frameworks
  • YouTube
    Video Players

Media & News

Alpha-1 Biologics's Email Address Formats

Alpha-1 Biologics uses at least 1 format(s):
Alpha-1 Biologics Email FormatsExamplePercentage
First.Last@alpha1biologics.comJohn.Doe@alpha1biologics.com
50%
First.Last@alpha1biologics.comJohn.Doe@alpha1biologics.com
50%

Frequently Asked Questions

Where is Alpha-1 Biologics's headquarters located?

Minus sign iconPlus sign icon
Alpha-1 Biologics's main headquarters is located at 25 Health Sciences Drive, Suite 110 Stony Brook, New York 11790, US. The company has employees across 2 continents, including North AmericaAsia.

What is Alpha-1 Biologics's phone number?

Minus sign iconPlus sign icon
You can contact Alpha-1 Biologics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Alpha-1 Biologics's official website and social media links?

Minus sign iconPlus sign icon
Alpha-1 Biologics's official website is alpha1biologics.com and has social profiles on LinkedIn.

What is Alpha-1 Biologics's SIC code NAICS code?

Minus sign iconPlus sign icon
Alpha-1 Biologics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Alpha-1 Biologics have currently?

Minus sign iconPlus sign icon
As of October 2025, Alpha-1 Biologics has approximately 5 employees across 2 continents, including North AmericaAsia. Key team members include Chief Executive Officer: C. B.Researcher: V. W.. Explore Alpha-1 Biologics's employee directory with LeadIQ.

What industry does Alpha-1 Biologics belong to?

Minus sign iconPlus sign icon
Alpha-1 Biologics operates in the Biotechnology Research industry.

What technology does Alpha-1 Biologics use?

Minus sign iconPlus sign icon
Alpha-1 Biologics's tech stack includes SquarespaceOpen GraphWebpackSquarespace CommerceGoogle Fonts APIJSON-LDStimulusYouTube.

What is Alpha-1 Biologics's email format?

Minus sign iconPlus sign icon
Alpha-1 Biologics's email format typically follows the pattern of First.Last@alpha1biologics.com. Find more Alpha-1 Biologics email formats with LeadIQ.

When was Alpha-1 Biologics founded?

Minus sign iconPlus sign icon
Alpha-1 Biologics was founded in 2011.

Alpha-1 Biologics

Biotechnology ResearchUnited States2-10 Employees

Alpha-1 Biologics is a biotherapeutics company developing innovative treatments for cancers and immune deficiencies. The company is dedicated to their mission to develop patented therapeutics related to the generation of immune cells from stem cells within the body to treat immunodeficiency with disease applications including immune cell replenishment in cancer therapy, HIV/AIDS, patients with inherited deficiency of α1PI, and in the most prevalent cause of immune deficiency, malnutrition. Alpha-1 Biologics is currently testing their orally-available, small molecules in studies to determine their ability to increase the number of tumor infiltrating CD4+ T cells and coordinate with immune checkpoint inhibitors to eliminate tumors. The discoveries at the core of Alpha-1 Biologics therapeutic approach resulted from basic research conducted by Dr. Bristow and supported for many years by the non-profit research organization, Institute for Human Genetics and Biochemistry (IHGB) funded by the Harry Winston Research Foundation.

Section iconCompany Overview

Headquarters
25 Health Sciences Drive, Suite 110 Stony Brook, New York 11790, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Alpha-1 Biologics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Alpha-1 Biologics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.